Beyond the myths: expanding the value of patient-centered research

Healthcare research is ultimately intended to inform decisions that affect patients' survival or quality of life. Yet the evidence used to make those decisions does not always capture the questions, outcomes, and experiences that matter most to the people living with a condition.

Patient-centered research (PCR) can help bridge that gap. At its core, PCR is research shaped by an understanding of patients’ priorities and lived experiences, including symptoms, burden of illness and treatment, cost implications, quality of life, and patients’ values and attitudes. It focuses on questions that matter to patients, comparisons that reflect the choices they face, and outcomes that are meaningful to their lives. Importantly, PCR is not a single study design or method. Rather, it is an approach that can be applied across the research lifecycle, from determining which questions to ask and what to measure to interpreting and communicating the findings. Yet three persistent myths can narrow how PCR is viewed: that it matters only to patients, that it is synonymous with patient-reported outcomes (PROs), and that it is too expensive, time-consuming, or difficult to put into practice.
 

Myth #1: Patients are the only ones who care about PCR

Patients are central beneficiaries of PCR, but its value extends across the healthcare ecosystem. Patient-centered evidence can support shared decision-making for clinicians, add context for regulators evaluating benefits and risks, inform payer policies, and help life sciences companies better understand treatment patterns.

Researchers also benefit. Engaging patients while developing a study can reveal practical issues that researchers might otherwise overlook, potentially improving feasibility, recruitment, retention, and data quality.

Patient perspectives can be especially valuable when claims or EHR data identify a pattern without explaining the decisions behind it. For example, the data may show that patients decline or discontinue treatment without revealing the role of treatment burden, quality of life, or patient preferences. PCR does not replace traditional outcomes such as survival.
 

Myth #2: PCR comes in only one form — patient-reported outcomes

Patient reported outcomes (PROs) are an important way to capture information directly from patients, but they represent just one way to operationalize PCR. PCR encompasses a much broader approach to incorporating patient perspectives into research.

PCR is study-design agnostic. Patient perspectives can inform a clinical trial, prospective observational study, or retrospective study using claims or EHR data. They can help shape research questions, comparators and outcomes, assess protocol feasibility, interpret findings, and guide how results are communicated.

Patient engagement also does not always require a separate study. Advisory panels, patient advocacy organizations, and existing qualitative or patient journey research can provide insights that inform research using existing real-world data (RWD). Patient-centeredness, then, is less about whether a particular type of data was collected and more about whether patient perspectives meaningfully influenced the evidence being generated.
 

Myth #3: PCR is too expensive, time-consuming, and difficult to put into practice

Some forms of PCR do require additional resources, planning, and expertise. The misconception is assuming that every meaningful application of PCR requires the most resource-intensive approach. A more practical goal is fit-for-purpose engagement: matching the approach to the research question, available resources, and decisions the evidence is intended to inform.

Organizations can support this by building relationships with patient communities before they are needed, developing researchers’ engagement skills, and preparing patient advisors to participate effectively. They can also document in protocols, reports, and

publications what changed because patients were involved, whether their input affected a research question, endpoint, protocol, or interpretation. Building the networks, capabilities, and practices to support that engagement can also make PCR easier to incorporate over time.

From better data to better evidence

PCR is a way of approaching research that asks researchers to consider the people behind the data and whether the evidence being generated reflects the questions, experiences, and outcomes that matter to them. Patient perspectives can help explain why, what it meant, and what may still be missing, creating evidence that is more useful across healthcare.